Patient-Reported Outcomes in the Phase III BRIGHTE Trial of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Individuals
Sarah Jane Anderson*, Miranda Murray, David Cella, Robert Grossberg, Debbie Hagins, William Towner, Marcia Wang, Andrew Clark, Amy Pierce, Cyril Llamoso, Peter Ackerman, Max Lataillade
Dive into the research topics of 'Patient-Reported Outcomes in the Phase III BRIGHTE Trial of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Individuals'. Together they form a unique fingerprint.